Cargando…

Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands

There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne β-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriace...

Descripción completa

Detalles Bibliográficos
Autores principales: Voets, Guido M., Platteel, Tamara N., Fluit, Ad C., Scharringa, Jelle, Schapendonk, Claudia M., Stuart, James Cohen, Bonten, Marc J. M., Hall, Maurine A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527366/
https://www.ncbi.nlm.nih.gov/pubmed/23284886
http://dx.doi.org/10.1371/journal.pone.0052102
_version_ 1782253707039080448
author Voets, Guido M.
Platteel, Tamara N.
Fluit, Ad C.
Scharringa, Jelle
Schapendonk, Claudia M.
Stuart, James Cohen
Bonten, Marc J. M.
Hall, Maurine A. L.
author_facet Voets, Guido M.
Platteel, Tamara N.
Fluit, Ad C.
Scharringa, Jelle
Schapendonk, Claudia M.
Stuart, James Cohen
Bonten, Marc J. M.
Hall, Maurine A. L.
author_sort Voets, Guido M.
collection PubMed
description There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne β-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriaceae with a minimal inhibitory concentration >1 mg/L for ceftazidime/ceftriaxone from a national survey (75% E. coli, 11% E. cloacae, 11% K. pneumoniae, 2% K. oxytoca, 2% P. mirabilis). Isolates were investigated for extended-spectrum β-lactamases (ESBLs) and ampC genes using microarray, PCR, gene sequencing and molecular straintyping (Diversilab and multi-locus sequence typing (MLST)). ESBL genes were demonstrated in 512 isolates (81%); of which 446 (87%) belonged to the CTX-M family. Among 314 randomly selected and sequenced isolates, bla (CTX-M-15) was most prevalent (n = 124, 39%), followed by bla (CTX-M-1) (n = 47, 15%), bla (CTX-M-14) (n = 15, 5%), bla (SHV-12) (n = 24, 8%) and bla (TEM-52) (n = 13, 4%). Among 181 isolates with MIC ≥16 mg/L for cefoxitin plasmid encoded AmpCs were detected in 32 and 27 were of the CMY-2 group. Among 102 E. coli isolates with MIC ≥16 mg/L for cefoxitin ampC promoter mutations were identified in 29 (28%). Based on Diversilab genotyping of 608 isolates (similarity cut-off >98%) discriminatory indices of bacteria with ESBL and/or ampC genes were 0.994, 0.985 and 0.994 for E. coli, K. pneumoniae and E. cloacae, respectively. Based on similarity cut-off >95% two large clusters of E. coli were apparent (of 43 and 30 isolates) and 21 of 21 that were typed by belonged to ST131 of which 13 contained bla (CTX-M-15). Our findings demonstrate that bla (CTX-M-15) is the most prevalent ESBL and we report a larger than previously reported prevalence of ampC genes among Enterobacteriaceae responsible for resistance to third-generation cephalosporins.
format Online
Article
Text
id pubmed-3527366
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35273662013-01-02 Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands Voets, Guido M. Platteel, Tamara N. Fluit, Ad C. Scharringa, Jelle Schapendonk, Claudia M. Stuart, James Cohen Bonten, Marc J. M. Hall, Maurine A. L. PLoS One Research Article There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne β-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriaceae with a minimal inhibitory concentration >1 mg/L for ceftazidime/ceftriaxone from a national survey (75% E. coli, 11% E. cloacae, 11% K. pneumoniae, 2% K. oxytoca, 2% P. mirabilis). Isolates were investigated for extended-spectrum β-lactamases (ESBLs) and ampC genes using microarray, PCR, gene sequencing and molecular straintyping (Diversilab and multi-locus sequence typing (MLST)). ESBL genes were demonstrated in 512 isolates (81%); of which 446 (87%) belonged to the CTX-M family. Among 314 randomly selected and sequenced isolates, bla (CTX-M-15) was most prevalent (n = 124, 39%), followed by bla (CTX-M-1) (n = 47, 15%), bla (CTX-M-14) (n = 15, 5%), bla (SHV-12) (n = 24, 8%) and bla (TEM-52) (n = 13, 4%). Among 181 isolates with MIC ≥16 mg/L for cefoxitin plasmid encoded AmpCs were detected in 32 and 27 were of the CMY-2 group. Among 102 E. coli isolates with MIC ≥16 mg/L for cefoxitin ampC promoter mutations were identified in 29 (28%). Based on Diversilab genotyping of 608 isolates (similarity cut-off >98%) discriminatory indices of bacteria with ESBL and/or ampC genes were 0.994, 0.985 and 0.994 for E. coli, K. pneumoniae and E. cloacae, respectively. Based on similarity cut-off >95% two large clusters of E. coli were apparent (of 43 and 30 isolates) and 21 of 21 that were typed by belonged to ST131 of which 13 contained bla (CTX-M-15). Our findings demonstrate that bla (CTX-M-15) is the most prevalent ESBL and we report a larger than previously reported prevalence of ampC genes among Enterobacteriaceae responsible for resistance to third-generation cephalosporins. Public Library of Science 2012-12-20 /pmc/articles/PMC3527366/ /pubmed/23284886 http://dx.doi.org/10.1371/journal.pone.0052102 Text en © 2012 Voets et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Voets, Guido M.
Platteel, Tamara N.
Fluit, Ad C.
Scharringa, Jelle
Schapendonk, Claudia M.
Stuart, James Cohen
Bonten, Marc J. M.
Hall, Maurine A. L.
Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
title Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
title_full Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
title_fullStr Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
title_full_unstemmed Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
title_short Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
title_sort population distribution of beta-lactamase conferring resistance to third-generation cephalosporins in human clinical enterobacteriaceae in the netherlands
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527366/
https://www.ncbi.nlm.nih.gov/pubmed/23284886
http://dx.doi.org/10.1371/journal.pone.0052102
work_keys_str_mv AT voetsguidom populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT platteeltamaran populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT fluitadc populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT scharringajelle populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT schapendonkclaudiam populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT stuartjamescohen populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT bontenmarcjm populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT hallmaurineal populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands
AT populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands